3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Stomatitis
3
Uterine Cervical Neoplasms
2
Skin Neoplasms
2
Laryngeal Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Interventions
Gemcitabine
15
Mitomycin
10
Docetaxel
7
BCG Vaccine
7
Cystoscopy
4
tislelizumab
3
durvalumab
3
Radiotherapy
3
Epirubicin
3
disitamab vedotin
2
avelumab
2
Hyaluronic Acid
2
tremelimumab
1
toripalimab
1
pemigatinib
1
pembrolizumab
1
monalizumab
1
lornoxicam
1
erdafitinib
1
enzalutamide
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
VPM1002 recombinant BCG vaccine
1
Urine Specimen Collection
1
Ty21a typhoid vaccine
1
Transurethral Resection of Bladder
1
Therapeutics
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-Muscle Invasive Bladder Neoplasms
×
Laser Therapy
×
Clear all
NCT05337397
2022-08-08
OPTIMA
Aarhus University Hospital
Recruiting
145 enrolled